You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 20, 2025

Drug Price Trends for NDC 70000-0422


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 70000-0422

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC: 70000-0422

Overview of the Drug

The NDC code 70000-0422-1 corresponds to a package of 355 ml in 1 bottle of Maximum Strength Antacid, a human over-the-counter (OTC) drug labeled by Cardinal Health[4].

Market Context for OTC Drugs

General Trends

OTC drugs, including antacids, are widely used and have a stable market demand. However, their pricing is often influenced by factors such as competition from generic or store-brand alternatives, regulatory changes, and consumer preferences.

Competitive Landscape

The antacid market is highly competitive, with numerous brands and generic options available. This competition typically keeps prices relatively stable, as consumers can easily switch between brands if prices become too high.

Pricing Dynamics

Current Pricing

As an OTC drug, the pricing of Maximum Strength Antacid is generally lower than that of prescription drugs. The wholesale acquisition cost (WAC) for such products is typically in the range of a few dollars per unit.

Historical Price Changes

For OTC drugs, significant price increases are less common compared to prescription drugs. According to data on prescription drug price changes, OTC drugs usually experience minimal to no price increases over time[3].

Regulatory Impact

Regulatory changes, such as those related to labeling or ingredients, can sometimes affect pricing. However, for OTC antacids, such changes are rare and typically do not lead to substantial price adjustments.

Market Performance Analysis

Sales Trends

Sales of OTC antacids tend to be consistent over time, driven by ongoing consumer demand for relief from heartburn and indigestion. The market performance of Maximum Strength Antacid would likely follow this trend, with stable sales volumes.

Comparative Added Clinical Benefit

Unlike prescription drugs, OTC antacids are not evaluated based on comparative added clinical benefit scores. Their market performance is more closely tied to consumer preference, brand loyalty, and marketing efforts.

Price Projections

Short-Term Projections

Given the stable nature of the OTC market and the competitive landscape, it is unlikely that the price of Maximum Strength Antacid will experience significant changes in the short term. Prices are expected to remain relatively stable, with minimal increases if any.

Long-Term Projections

In the long term, the price of Maximum Strength Antacid may see slight adjustments due to inflation or changes in production costs. However, these changes are expected to be minimal and not drastic.

Impact of Broader Market Factors

Medicare and Prescription Drug Price Negotiations

While the Medicare Drug Price Negotiation Program significantly impacts prescription drug prices, it does not directly affect OTC drugs like Maximum Strength Antacid[2][5].

Economic Factors

Economic factors such as inflation can influence the pricing of OTC drugs. However, these effects are generally muted compared to prescription drugs, and price increases would be expected to be in line with overall inflation rates.

Consumer Behavior and Preferences

Consumer behavior plays a crucial role in the market performance of OTC antacids. Brand loyalty, advertising, and the availability of alternative products can influence sales. However, given the essential nature of antacids, demand is likely to remain consistent.

Key Takeaways

  • Stable Market Demand: The demand for OTC antacids like Maximum Strength Antacid is consistent and driven by ongoing consumer needs.
  • Minimal Price Changes: Prices for OTC antacids are expected to remain relatively stable with minimal increases.
  • Competitive Landscape: The competitive nature of the antacid market keeps prices in check.
  • Regulatory Stability: Regulatory changes are unlikely to significantly impact the pricing of OTC antacids.
  • Consumer Behavior: Consumer preferences and brand loyalty are key drivers of sales but are not expected to lead to significant price changes.

FAQs

Q: What is the NDC code 70000-0422-1 for?

A: The NDC code 70000-0422-1 is for a package of 355 ml in 1 bottle of Maximum Strength Antacid, an OTC drug labeled by Cardinal Health.

Q: How does the competitive landscape affect the pricing of Maximum Strength Antacid?

A: The competitive landscape keeps prices relatively stable as consumers can easily switch between brands if prices become too high.

Q: Are there any regulatory changes that could impact the pricing of Maximum Strength Antacid?

A: Regulatory changes are rare for OTC antacids and typically do not lead to substantial price adjustments.

Q: How do broader market factors like inflation affect the pricing of OTC antacids?

A: Inflation can influence pricing, but the effects are generally muted, and price increases would be expected to be in line with overall inflation rates.

Q: What is the expected long-term price projection for Maximum Strength Antacid?

A: The price is expected to remain relatively stable with minimal adjustments due to inflation or changes in production costs.

Sources

  1. NCBI: MARKET PERFORMANCE ANALYSIS - Antimicrobial Drugs
  2. ASPE - HHS.gov: Medicare Drug Price Negotiation Program
  3. ASPE - HHS.gov: Changes in the List Prices of Prescription Drugs, 2017-2023
  4. NDC List: NDC Package 70000-0422-1 Maximum Strength Antacid
  5. CMS: Medicare Drug Price Negotiation Program - CMS

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.